Functional type II VIP-PACAP receptors in human airway epithelial-like cells

Peptides

Volumn 18, Issue 6, 1997, Pages 843-846

  Lindén, Anders ^a   Yoshihara, Shigemi ^a   Cardell, Lars Olaf ^a   Kaneko, Takeshi ^a   Stjärne, Pär ^a   Nadel, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calu 3 cells; cAMP; Epithelium; Human; Neuropeptides; PACAP; Peptidase; Peptide receptor; VIP

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CAPTOPRIL; CYCLIC AMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; ISOPRENALINE; PHOSPHORAMIDON; VASOACTIVE INTESTINAL POLYPEPTIDE;

AIRWAY PRESSURE; ARTICLE; CALORIMETRY; COMPUTER PROGRAM; DNA DETERMINATION; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PANCREAS CELL; PRIORITY JOURNAL; RESPIRATORY FUNCTION;

CAPTOPRIL; CYCLIC AMP; EPITHELIUM; GLYCOPEPTIDES; HUMANS; ISOPROTERENOL; LUNG; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEASE INHIBITORS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; TUMOR CELLS, CULTURED; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0030852305     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00017-X     Document Type: Article

References (31)

1. Berthon P., Mirossay L., Ito S, Calvo F., Gespach C. Functional expression of VIP receptors in normal, immortalized and transformed mammary epithelial cells. Life Sci. 50:1992;791-798.
2. Bhogal R., Sheldrick R. L. G., Coleman R. A., Smith D. M., Bloom S. R. The effects of PACAP and VIP on guinea pig tracheal smooth muscle in vitro. Peptides. 15:1994;1237-1241.
3. Caughey G. H., Leidig F., Viro N. F, Nadel J. A. Substance P and vasoactive intestinal polypeptide degradation by mast cell tryptase and chymase. J. Pharmacol. Exp. Ther. 24:1988;133-137.
4. Cesarone C. F., Bolognesi C., Santi L. Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal. Biochem. 100:1979;188-197.
5. Chastre E., Gioia Y. D., Barbry P., Simon-Bouy B., Mornet E., Fanen P., Champigny G., Emami S., Gespach C. Functional insertion of the SV40 large oncogene in cystic fibrosis intestinal epithelium. J. Biol. Chem. 266:1991;21239-21246.
6. Chedeville A., Mirrossay L., Chastre E., Hurbain-Kosmath I., Lopez M., Gespach C. Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages. FEBS Lett. 319:1993;171-176.
7. Coleman D. T., Bancroft C. Pituitary adenylate cyclase-activating polypeptide stimulates prolactin gene expression in a rat pituitary cell line. Endocrinology. 133:1993;2736-2742.
8. Cozens A. L., Yezzi M. J., Kunzelmann K., Ohrui T., Chin L., Eng K., Finkbeiner W. E., Widdicombe J. H., Gruenert D. C. CFTR expression and chloride seceretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10:1994;38-47.
9. Favit A., Scapagnini U., Canonico P. L. Pituitary adenylate cyclase-activating polypeptide activates different signal transducing mechanisms in cultured cerebellar granule cell. Neuroendocrinology. 61:1995;377-382.
10. Foda H. D., Sharaf H. H., Absood A., Said S. Pituitary adenylate cyclase-activating peptide (PACAP), a VIP-like peptide, has prolonged airway smooth muscle relaxant activity. Peptides. 16:1995;1057-1061.
11. Franconi G. M., Graf P., Lazarus S. C, Nadel J. A., Caughey G. H. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret. J. Pharm. Exp. Ther. 248:1989;947-951.
12. Harmer T., Lutz E. M. Multiple receptors for PACAP and VIP. TIPS. 15:1994;97-99.
13. Johnson A. R., Ashton J., Schulz W. W., Erdös E. G. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am. Rev. Respir. Dis. 132:1985;564-568.
14. Kaneko T., Ueki I., Nadel J. A. Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils. Cell. Sign. 7:1995;527-534.
15. +-ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide. Res. Communic. Chem. Pathol. Pharmacol. 79:1993;11-22.
16. Kastner A., Bruch L., Rubel S., Gellert C., Witt C. Pituitary adenylate cyclase activating peptides dilate human pulmonary arteries by activation of different types of K-channels. Am. J. Respir. Crit. Care Med. 153:1996;A586.
17. Lee M., Jensen R. T., Huang S. C., Bepler G., Korman L., Moody T. W. Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cyclic AMP levels. Peptides. 11:1990;1205-1209.
18. Lilly C. M., Kobzik L., Hall A. E., Drazen J. M. Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs. J. Clin. Invest. 93:1994;2667-2674.
19. Liu L. W., Sata T., Kubota E., Paul S., Said S. Airway relaxant effect of vasoactive intestinal peptide (VIP): Selective potentiation by phosphoramidon, an enkephalinase inhibitor. Am. Rev. Respir. Dis. 135:1987;A86.
20. Luts A., Uddman R., Alm P., Basterra J., Sundler F. Peptide-containing nerve fibers in human airways: Distribution and coexistence pattern. Int. Arch. Allergy Immunol. 101:1993;52-60.
21. Miyata A., Arimura A., Dahl R. R., Minamino N., Uehara A., Jiang L., Culler M. D., Coy D. H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Com. 164:1989;567-574.
22. Nathanson I., Widdicombe J. H., Barnes P. Effect of vasoactive intestinal peptide on ion transport across dog tracheal epithelium. J. Appl. Physiol. Respirat. Environ. Exercise Physiol. 55:((6)):1983;1844-1848.
23. Sakai N., Tamaoki J., Kanemura T., Isono K., Takeyama K., Takeuchi S., Takizawa T. Vasoactive intestinal peptide stimulates ciliary motility in rabbit tracheal epithelium: Modulation by neutral endopeptidase. Reg. Peptides. 34:1991;33-41.
24. Salomon R., Couvineau A., Royer-Fessard C., Voisin T., Lavallée D., Blais A., Darmoul D., Laburthe M. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium. Am. J. Physiol. 264:([Endocrinol. Metab. 27]):1993;E294-E300.
25. Schmidt W. E., Seebeck J., Höcker M., Schwarzhoff R., Schäfer H., Fornefeld H., Morys-Wortmann C., Fölsch U. R., Creutzfeldt W. PACAP and VIP stimulate enzyme secretion in rat pancreatic acini via interaction with VIP/PACAP-2 receptors: Additive augmentation of CCK/carbachol-induced enzyme release. Pancreas. 8:1993;476-487.
26. Shen B. Q., Finkbeiner W. E., Wine J. J., Mrsny R. J., Widdicombe J. H. CALU-3: A human airway epithelial cell line that shows cAMP-dependent Cl-secretion. Am. J. Physiol: Lung Cell. Mol. Physiol. 10:1994;L493-L501.
27. Tam E. K., Caughey G. H. Degradation of airway neuropeptides by human lung tryptase. Am. J. Cell. Mol. Biol. 3:1990;27-32.
28. Uddman R., Luts A., Arimura A., Sundler F. Pituitary adenylate cyclase-activating peptide (PACAP), a new vasoactive intestinal peptide (VIP)-like peptide in the respiratory tract. Cell Tissue Res. 265:1991;197-201.
29. Widdicombe J. H., Ueki I. F., Emery D., Margolskee D., Yergey J., Nadel J. A. Release of cyclooxygenase products from primary cultures of tracheal epithelia of dog and human. Am. J. Physiol. 257:([Endocrinol. Metab. 27]):1989;L361-365.
30. Zhong Y. Mediation of PACAP-like neuropeptide transmission by coactivation of Ras/Raf and cAMP signal transduction pathways in Drosophila. Nature. 375:1995;588-591.
31. Zia F., Fagarasan M., Bitar K., Coy D. H., Pisegna J. R., Wank S. A., Moody T. W. Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancers. Cancer Res. 55:1995;4886-4891.